These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4295707)

  • 1. [Effects of angiotensin on the kidney in liver cirrhosis].
    Kuntzmann F; Reville P; Kurtz T; Vassaux C; Jahn H; Stahl J
    Pathol Biol; 1967 Dec; 15(23):1133-44. PubMed ID: 4295707
    [No Abstract]   [Full Text] [Related]  

  • 2. [The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
    Ventura E; Zeneroli ML
    Folia Endocrinol; 1969 Dec; 22(4):345-53. PubMed ID: 4329093
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of aldosterone and angiotensin on renal function.
    Louis WJ; Doyle AE
    Clin Sci; 1966 Apr; 30(2):179-89. PubMed ID: 4287511
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of furosemide uring antidiuresis and antinatriuresis induced by angiotensin.
    Radó JP; Borbély L; Takó J; Bános C
    Med Pharmacol Exp Int J Exp Med; 1967; 17(4):373-7. PubMed ID: 4296659
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some aspects of the action of angiotensin on the kidney].
    Jahn H; Reville P; Kurtz T; Kuntzmann F; Stahl J
    Pathol Biol; 1967; 15(11):641-8. PubMed ID: 4292970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transient anuria in decompensated liver cirrhosis during angiotensin (Hypertensin) infusion].
    Radó J; Borbély L; Kalcseva S; Takó J; Szende L
    Orv Hetil; 1969 Feb; 110(8):407-10. PubMed ID: 4305316
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of furosemide on diuresis and salt diuresis, blood electrolytes concentrations in various aspects of renal function in liver cirrhotic patients with ascites].
    Bardi A; Merino I; Doerr E; Rendic Y; Generini G; Plaza de los Reyes M
    Rev Med Chil; 1968 Mar; 96(3):142-4. PubMed ID: 5732745
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibition of natriuretic effect of angiotensin by spirolactones and salidiuretics in cirrhosis and arterial hypertension].
    Kuntzmann F; Reville P; Kurtz T; Jahn H; Stahl J
    Pathol Biol (Paris); 1969 May; 17(9):447-58. PubMed ID: 4308377
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sympathicus blockade and increased blood flow through the kidneys on the action of angiotensin on the kidney function in hypertensives].
    Ripka O
    Bratisl Lek Listy; 1969; 51(5):569-76. PubMed ID: 4307273
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the renal action of angiotensin II in man. Direct and indirect effects].
    Agnoli GC; Cariani A; Farné F; Montini T
    Minerva Nefrol; 1973; 20(2):66-73. PubMed ID: 4355937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
    Gu XB; Chen HK; Zhu YF; Pei H; Liu XY
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):370. PubMed ID: 15225438
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect differences between angiotensin II and noradrenalin in reference to diuresis, sodium and potassium excretion in healthy persons and patients with kidney diseases].
    Pogglitsch H; Giessauf W; Stöckl G; Feldner H; Kratochvil K
    Wien Z Inn Med; 1970; 51(7):324-9. PubMed ID: 4331448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiotensin-aldosterone interrelations in hepatic cirrhosis].
    Runcan V; Buligescu L; Tutunaru M
    Med Interna (Bucur); 1970 Jun; 22(6):697-704. PubMed ID: 4318491
    [No Abstract]   [Full Text] [Related]  

  • 17. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-induced natriuresis in cirrhosis in the absence of endogenous aldosterone secretion.
    McCloy RM; Baldus WP; Summerskill WH; Maher FT
    Ann Intern Med; 1966 Jun; 64(6):1271-6. PubMed ID: 4286738
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal function in cirrhotic patients. II. Tubular reabsorption of sodium and diuresis].
    Solís Herruzo JA; Pardo Rueda J
    Rev Clin Esp; 1971 Jul; 122(2):99-110. PubMed ID: 5164616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.